Christopher Astle, SVP & Chief Financial Officer at Zymeworks Inc. (ZYME), sold 886 shares at $9.13 ($8K) on 2023-12-11, disclosed to the SEC on 2023-12-11.
Open-market sale of $8k ZYME by SVP & Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |